← Eichor
Study identifier: NCT06827678 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Establishment of the Chinese Preclinical Alzheimer's Disease Study With Multiple Neuroimaging

Condition: Alzheimer Disease · Positron Emission Tomography  ·  Sponsor: Huashan Hospital

PhaseN/A
Planned participants3000
Who can joinAll sexes, 45 Years to 90 Years
Healthy volunteersYes

About this study

The goal of this observational study is to investigate neuroimage and biomarkers in the Alzheimer's continuum in Chinese population. We aimed to: * To reveal the progress of AD by multiple neuroimage and biomarkers; * To reveal the longitudinal change of biomarkers and cognition of AD in Chinese population; * To investigate the interaction of markers between body and brain; * To set up new markers by neuroimage.

This description comes directly from the study's public registry record.

Talk to the study team

Yihui Guan, MD  ·  +8613764308300  ·  guanyihui@hotmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Huashan HospitalShanghai, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06827678